Given that T-cell exhaustion is the self-protective mechanism for dysregulation of immune reaction, patients with impaired lung function might be vulnerable to ICI therapy as blockade of PD-1/PD-L1 pathway, causing airway injury, lung function decline, or pneumonitis. This evidence concerns the gene CD274 and pneumonitis.